The fate of N1′-methanesulphonyl-N4′-(9-acridinyl) -3′ -methoxy-2′,5′ -cyclohexadiene-1′,4′-diimine (m-aqdi), the primary oxidative metabolite of amsacrine, in transformed chinese hamster fibroblasts

This publication has 27 references indexed in Scilit:

• Reactivity of quinone imine and quinone diimine metabolites of the antitumor drug amsacrine and related compounds to nucleophiles
  The Journal of Organic Chemistry, 1988
• DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy
  Pharmacology & Therapeutics, 1987
• Formation of the thiol adducts of 4′-(9-acridinylamino)methanesulfon-m-anisidide and their binding to deoxyribonucleic acid
  Biochemical Pharmacology, 1986
• Identification of the active species in deoxyribonucleic acid breakage induced by 4′-(9-acridinylamino)methanesulfon-m-anisidide and copper
  Biochemical Pharmacology, 1986
• Selective toxicity of nitracrine to hypoxic mammalian cells
  British Journal of Cancer, 1984
• Acetaminophen Hepatotoxicity
  Annual Review of Medicine, 1984
• Field desorption mass spectrometric characterization of thiol conjugates related to the oxidative metabolism of the anticancer drug 4′-(9-acridinylamino)-methanesulfon-m-anisidide
  Journal of Mass Spectrometry, 1983
• Metabolism of the anti-tumour drugsN2-methyl-9-hydroxyellipticinium acetate (NSC 264137) andN2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates
  Xenobiotica, 1983
• Identification of conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4′-(9-acridinylamino)methanesulfon-m-anisidide
  Journal of Mass Spectrometry, 1981
• Thiolytic cleavage of the anti-tumour compound 4′-(9-acridinylamino)-methanesulphon-m-anisidine (m-AMSA, NSC 156 303) in blood
  Chemico-Biological Interactions, 1977